Fremanezumab 225 Mg/1.5 mL Subcutaneous Solution

DRUG2 trials

Sponsors

Otsuka Pharmaceutical Co., Ltd., Insel Gruppe AG, University Hospital Bern

Conditions

Acute Mountain SicknessMigraine Disorders

Phase 4

Calcitonin Gene-related Peptide Antibody in Acute Mountain Sickness

Not yet recruitingNCT07653516

Insel Gruppe AG, University Hospital BernAcute Mountain Sickness

Start: 2027-06-01End: 2027-07-31Target: 30Updated: 2026-07-01

Unknown Phase

Specified Drug Use Survey on AJOVY Subcutaneous Injection for Long-term Use

RecruitingNCT05342493

Otsuka Pharmaceutical Co., Ltd.Migraine Disorders

Start: 2022-04-20End: 2029-06-22Target: 1000Updated: 2026-06-22